| MYOZ2 |
MYOZ2, C4orf5: Myozenin-2 |
DTNB |
DTNB: Dystrobrevin beta |
0.36 |
Evidence |
|
| BCL2L14 |
BCL2L14, BCLG: Apoptosis facilitator Bcl-2-like 14 protein |
RTN4 |
RTN4, KIAA0886, My043, NOGO, SP1507: Reticulon-4 |
0.36 |
Evidence |
|
| PARD6G |
PARD6G, PAR6G: Partitioning defective 6 homolog gamma |
TNIK |
TNIK, KIAA0551: TRAF2 and NCK-interacting protein kinase |
0.36 |
Evidence |
|
| PARD6G |
PARD6G, PAR6G: Partitioning defective 6 homolog gamma |
TJP2 |
TJP2, X104, ZO2: Tight junction protein ZO-2 |
0.36 |
Evidence |
|
| SIN3A |
SIN3A: Paired amphipathic helix protein Sin3a |
ZNF278 |
PATZ1, PATZ, RIAZ, ZBTB19, ZNF278, ZSG: POZ-, AT hook-, and zinc finger-containi |
0.36 |
Evidence |
|
| SCMH1 |
SCMH1: Polycomb protein SCMH1 |
SFMBT1 |
SFMBT1, RU1: Scm-like with four MBT domains protein 1 |
0.36 |
Evidence |
|
| SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
C6orf21 |
LY6G6F, C6orf21, G6F, LY6G6D, NG32: Lymphocyte antigen 6 complex locus protein G |
0.36 |
Evidence |
|
| EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
EPHA10 |
EPHA10: Ephrin type-A receptor 10 precursor |
0.36 |
Evidence |
|
| PPFIA1 |
PPFIA1, LIP1: Liprin-alpha-1 |
DBNL |
DBNL, CMAP, PP5423, SH3P7: Drebrin-like protein |
0.36 |
Evidence |
|
| DUSP4 |
DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 |
GRB10 |
IPI00012752 |
0.36 |
Evidence |
|
| PCDH1 |
PCDH1: Protocadherin-1 precursor |
PCDHGA9 |
PCDHGA9: Protocadherin gamma A9 precursor |
0.36 |
Evidence |
|
| PCDH1 |
PCDH1: Protocadherin-1 precursor |
PCDHGB4 |
IPI00028619 |
0.36 |
Evidence |
|
| ZXDA |
ZXDA: Zinc finger X-linked protein ZXDA |
SIN3A |
SIN3A: Paired amphipathic helix protein Sin3a |
0.36 |
Evidence |
|
| SHC2 |
IPI00401979 |
CDC42EP1 |
CDC42EP1, BORG5, CEP1, MSE55: Cdc42 effector protein 1 |
0.36 |
Evidence |
|
| GNG3 |
GNG3, GNGT3: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 p |
GNB2L1 |
Lung cancer oncogene 7 |
0.36 |
Evidence |
|
| GNG2 |
GNG2: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 precurso |
GNB2L1 |
Lung cancer oncogene 7 |
0.36 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
SCAP2 |
SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 |
0.36 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
IL10RB |
IL10RB, CRFB4, D21S58, D21S66: Interleukin-10 receptor beta chain precursor |
0.36 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
TYRO3 |
TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor |
0.36 |
Evidence |
|
| GNG4 |
GNG4, GNGT4: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 p |
GNB2L1 |
Lung cancer oncogene 7 |
0.36 |
Evidence |
|
| GSK3B |
GSK3B: Glycogen synthase kinase-3 beta |
PARD6B |
PARD6B, PAR6B: Partitioning defective 6 homolog beta |
0.36 |
Evidence |
|
| RGS7 |
RGS7: Regulator of G-protein signaling 7 |
GPR62 |
GPR62: Probable G-protein coupled receptor 62 |
0.36 |
Evidence |
|
| RGS7 |
RGS7: Regulator of G-protein signaling 7 |
C9orf47 |
EDG3: Sphingosine 1-phosphate receptor Edg-3 |
0.36 |
Evidence |
|
| PIP5K2A |
PIP4K2A, PIP5K2, PIP5K2A: Phosphatidylinositol-5-phosphate 4-kinase type-2 alpha |
BTK |
IPI00735413 |
0.36 |
Evidence |
|
| BDKRB1 |
BDKRB1, BRADYB1: B1 bradykinin receptor |
RGS7 |
RGS7: Regulator of G-protein signaling 7 |
0.36 |
Evidence |
|